Have a personal or library account? Click to login
Development and validation of spectrophotometric methods for determination of ceftazidime in pharmaceutical dosage forms Cover

Development and validation of spectrophotometric methods for determination of ceftazidime in pharmaceutical dosage forms

Open Access
|Dec 2008

Abstract

Two spectrophotometric methods for the determination of ceftazidime (CFZM) in either pure form or in its pharmaceutical formulations are described. The first method is based on the reaction of 3-methylbenzothiazolin-2-one hydrazone (MBTH) with ceftazidime in the presence of ferric chloride in acidic medium. The resulting blue complex absorbs at λmax 628 nm. The second method describes the reaction between the diazotized drug and N-(1-naphthyl)ethylenediamine dihydrochloride (NEDA) to yield a purple colored product with λmax at 567 nm. The reaction conditions were optimized to obtain maximum color intensity. The absorbance was found to increase linearly with increasing the concentration of CFZM; the systems obeyed the Beer's law in the range 2-10 and 10-50 μg mL-1 for MBTH and NEDA methods, resp. LOD, LOQ and correlation coefficient values were 0.15, 0.79 and 0.50, 2.61. No interference was observed from common excipients present in pharmaceutical formulations. The proposed methods are simple, sensitive, accurate and suitable for quality control applications.

DOI: https://doi.org/10.2478/v10007-008-0017-0 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 275 - 285
Published on: Dec 22, 2008
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2008 Basavaraj Hiremath, Bennikallu Mruthyunjayaswamy, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 58 (2008): Issue 3 (September 2008)